Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now full pipeline small index

Colon Polyps: full-pipeline trial registry

2 of 6 indexed Colon Polyps trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Colon Polyps: 6 US clinical trials tracked, 2 recruiting.

Colon Polyps is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Danielle Kim Turgeon, running 1 of these trials.

Enrollment posture brief

Registry condition colon-polyps

OPEN 2 | RECR 33% | LATE 1 | EARLY 1 | RANK #2866 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Colon Polyps (this)33%
Open-enrollment share among volume-matched conditions near Colon Polyps

Colon Polyps lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Colon Polyps on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Colon Polyps is recruiting below its size-band peers.

    2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Colon Polyps research.

    Danielle Kim Turgeon accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Colon Polyps enrolment sits around 139 participants.

    Median target enrolment is 139 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.

  4. Colon Polyps splits between interventional and observational designs.

    4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 31

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1

Named interventions

Most-linked intervention names on Colon Polyps records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Hextend Drug
1 trials
Lactated Ringers Drug
1 trials
Medivators Endocuff Device
1 trials
Olympus transparent cap Device
1 trials
Colon KCC Heptapeptide Biological
1 trials
Colonoscopy without Computer-Aided Detection Procedure
1 trials
Colonoscopy With Computer-Aided Detection Device
1 trials
Control Device
1 trials

US sites by state

Facility locations filed on Colon Polyps trials. A trial with sites in several states counts in each.

Michigan 2 trials
Texas 1 trials
Ohio 1 trials
Illinois 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Colon Polyps page

6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Colon Polyps condition card totals 6 registered trials; most-linked intervention Hextend; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.